Both in Pharmaceuticals
ABBVIE vs Abbott Laboratories
Over the past year ABBV returned +19.3% and ABT returned −24.1%; their daily moves had a correlation of 0.27.
ABBV +19.3% ABT −24.1%Growth of $1, one year, split-adjusted
| Metric | ABBV | ABT |
|---|---|---|
| Price | $266.28 | $100.98 |
| Market cap | $470.55B | $174.73B |
| Today | +0.73% | −0.31% |
| 1 month | +3.1% | −9.5% |
| 6 months | +27.2% | −2.9% |
| Year to date | +16.5% | −19.4% |
| 1 year | +21.8% | −24.3% |
| Revenue growth (YoY) | +10.2% | +13.0% |
| Gross margin | 74.7% | 57.7% |
| Net margin | 21.3% | 7.4% |
| P/E (TTM) | 74.8× | 32.2× |
| Price / sales | 7.3× | 3.8× |
| Net cash | -$64.25B | -$27.00B |
| Dividend yield | 2.60% | 2.50% |
| Volatility (60d) | 21.8% | 29.9% |
| Short % of float | 1.1% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).